eISSN 2508-3589
pISSN 2508-1926

Fig. 4.

Download original image
Fig. 4. The mean change in (A) BCVA and (B) CMT from baseline to 12 months for patients with typical neovascular age-related macular degeneration (AMD) and with polypoidal choroidal vasculopathy (PCV). (A) There was no significant difference in BCVA changes between the typical AMD group and PCV group. (B) At month 5, CMT change showed a significantly greater decrease in the PCV group than the typical AMD group. BCVA = best-corrected visual acuity; logMAR = logarithm of the minimum angle of resolution; CMT = central macular thickness. *p < 0.05.
J Retin 2021;6:99-109 https://doi.org/10.21561/jor.2021.6.2.99
© 2021 J Retin